The impact of epilepsy on the quality of life of older people with epilepsy has rarely been investigated. As part of a large prevalence study of epilepsy conducted in one UK Health Region, we investigated the burden of their condition in older compared with younger people. A second analysis compared quality of life in those men and women diagnosed after the age of retirement from the workforce compared with those diagnosed before that age.
INTRODUCTION
Despite an awareness of the increase in the incidence and prevalence of epilepsy after the age of 60 [1] [2] [3] [4] , there is relatively little documented about the impact of this condition on the everyday lives of older people 5 .
Epidemiological studies have highlighted that epilepsy is, however, the third most common neurological condition of older age, after cardiovascular accidents and dementia and subsequently represents a significant health problem. According to Tallis 6 , the occurrence of seizures may represent a 'significant watershed in an older person's life after which there is a sharp decline in functional independence'.
Earlier studies have shown that the clinical manifestation of seizures in older people can be quite different from those in younger patients, with prolonged postictal states and an increased incidence of Todd's phenomena especially postictal hemiparesis 7, 8 , often resulting in injuries which, because of the ageing process, may also be more serious. A history of seizure activity is frequently inadequate and distinguishing seizures from cardiovascular causes of episodic loss of consciousness can be particularly difficult. Seizures are often symptomatic and more likely due to underlying focal cerebral lesions, in particular cerebrovascular disease 9 . Concurrent pathology unrelated to the seizures is common and the older person with epilepsy will frequently be on medication additional to antiepileptic drugs (AEDs). The issue of the side-effects of AED treatment on cognitive functioning in older people with epilepsy has yet to be systematically addressed although a decrease in cognitive functioning associated with the ageing process may be intensified by the effects of AEDs. A number of authors have suggested that epilepsy in older people can have both immediate and less immediate deleterious consequences for quality of life (QOL). Loss of confi-dence, increased social isolation, poor self esteem and increased levels of anxiety and depression have been suggested as important contributions to reduced QOL in older people with epilepsy 6, 10 , although to date evidence is based on clinical anecdotal experience and no formal QOL studies have been conducted to examine these effects.
In order to determine the impact of epilepsy in this group of patients we examined the data from a large cross-sectional study of epilepsy in the community 11, 12 . The overall aim of the community study was to assess levels of disability and handicap in a population of people of all ages with active epilepsy; and to identify clinical, social and psychological factors associated with them. The study also aimed to examine the quality of primary and secondary care provided to people with epilepsy. A QOL questionnaire, based on the Liverpool QOL Battery 13 and containing measures of physical, social and psychological well-being as well as information on clinical and demographic status, was administered to 1180 adult subjects in the Mersey Region in the United Kingdom. The purpose of this paper is to compare and contrast the QOL profile of older vs. younger people with epilepsy. Definitions of 'older' in previous studies are inconsistent 14 ; for the purposes of the present study, we have adopted a cut-off point of 60 years in women and 65 years in men, reflecting the normal retirement age in the UK. An additional hypothesis that we wished to explore was whether age of onset of epilepsy is a critical variable determining QOL of older people. Our supposition was that those diagnosed prior to retirement from paid employment would report a more severely compromised QOL than those diagnosed later. A further comparison was therefore made between older people diagnosed after the age of retirement from the work force and older people diagnosed before that point in their working lives.
MATERIALS AND METHODS
Individuals within the study were drawn from a trawl of the records of 31 general practitioners in the UK 11 . General practices were randomly selected to be representative of single-handed, small and large group practices and of urban, inner city and rural practices in the Mersey region. Individuals were deemed as having established epilepsy and so eligible to participate in the study if they had had a seizure in the past 2 years or were seizure-free but currently taking AEDs. Individuals participating in the study were identified from the practice morbidity and repeat prescription registers. A hospital consultant confirmed a diagnosis of epilepsy in 70% of the cases; in the remaining 30% a diagnosis was made by the general practitioner. Of the original 1190 adults identified from the general practitioners' records, 215 had learning disabilities or physical health problems severe enough to prevent them from participating in the study or could not be traced and so were excluded. Nine hundred and seventyfive adults were therefore identified as eligible. For those eligible to participate, clinical information about their epilepsy was abstracted from the medical records held by the general practices. Information was collected on the first and most recent seizure, aetiology of epilepsy, classification of seizure types and the presence of any health problems other than epilepsy (mental or neurological handicap, psychiatric disorder and other chronic medical disorder).
Postal questionnaires were then sent out to these 975 individuals asking them about their QOL and the quality of services they received in respect of their epilepsy. Six hundred and ninety-six adults (72% response rate) returned a usable questionnaire; 27 of whom were excluded from the present analysis because information was not available as to their age, leaving 669 individuals who could be included. There was no difference between the responders and nonresponders for current seizure activity (53% cf. 58%, P = 0.08); there was also no difference for duration of epilepsy (9 years in both groups); age of onset was somewhat later in non-responders than in responders (27 years cf. 22 years). A detailed description of differences in the clinical and demographic characteristics of responders, non-responders and those classed as ineligible is provided elsewhere 11 . 11 Education/ Overall QOL 20 employment status 11 Injuries 24 Marital status 11 Side-effects 15 The health-related QOL questionnaire
Each individual who participated in the study completed a questionnaire battery containing validated measures of physical, social and psychological functioning, various questions about their epilepsy and questions relating to their demographic characteristics (see Table 1 ).
Contents of the questionnaire
The impact of epilepsy scale and the adverse events profile were specifically designed by the study team to be sensitive to the problems associated with the assessment and treatment of epilepsy and its impact on day to day functioning.
The Impact of Epilepsy scale is an 8-item scale developed to assess the impact of epilepsy and antiepileptic drug therapy on individuals' relationships with friends and family, social life, employment, health, self-esteem, plans for the future and standard of living. It is scored on a simple Likert scoring system. This scale was designed specifically to assess the psychosocial consequences of living with epilepsy and its treatment. Acceptable levels of reliability and validity of the scale have been reported elsewhere 15 .
The Adverse Drug Events Profile (AEP) is a 19-item checklist developed to quantify patients' perceptions of the side-effects of antiepileptic drug treatment. It contains items relating to both CNS and non-CNS dose-related side-effects. The profile has been shown to be of good reliability, good construct and discriminant validity 16 and in a recent study, to discriminate reliably between four standard AEDs. Patients often complain about antiepileptic drugs and side-effects and this scale reflects an important aspect of living with epilepsy and its treatment.
The Hospital Anxiety and Depression scale (HAD) is an established measure of patients' perception of their current level of psychological functioning. It contains 14 items, seven relating to anxiety and seven relating to depression. Scoring for each item is on a 0-3 scale. A score of 0-7 represents a non-case of anxiety or depression, a score of 8-10 represents a borderline case and a score of 11+ represents a clinical case 17 . The Hospital Anxiety and Depression scale has been shown to correlate highly with psychiatric assessment 18 .
The Stigma scale is a 3-item scale adapted from a measure originally designed to assess the perceived stigma of a stroke and revised to make it applicable to epilepsy 19, 20 . It has a simple scoring system of 0 or 1 for each item; a score of 3 represents the perception of being severely stigmatized by the epilepsy. Evidence of its reliability and validity has been welldocumented 11, 19 .
The Terrible-Delighted Faces, developed by Andrews and Withey 21 as a global QOL measure, was used as a summary measure of respondents' overall life quality. This is in line with the recommendation that QOL assessments should include a summary measure as well as measures of individual QOL domains 22 . Respondents were asked to say which of seven facial expressions, ranging from terrible to delighted, came closest to the way they felt about life as a whole.
Demographic and epilepsy-related variables: Single items were used to elicit information about current education and employment status and marital/living status. Information relating to seizure type, seizure frequency, age of onset, duration of epilepsy, current AED medication (type but not dose), and any seizurerelated injuries occurring in the past 12 months, was also collected from patients participating in the study. Patients were asked to categorize their seizures as: major seizures only; major and other seizures; other seizures only; and as occurring once or more per month, less often than once a month, or not at all in the last year (seizure-free).
Statistical analysis
In order to examine the relationship between the physical, social and psychological aspects of epilepsy and older age we compared four groups: all men aged <65 and all women aged <60 at the time of data collection (Group 1); and all men aged 65+ and all women aged 60+ (Group 2); all men aged 65+ at the time of data collection and diagnosed before the age of 65 and all women aged 60+ diagnosed before the age of 60 (Group 2a); and all men aged 65+ diagnosed at 65 or over and all women aged 60+ diagnosed at 60 or over (Group 2b). The cut-off points selected represent the normal age of retirement from paid employment for men and women in the UK. Data from the questionnaire batteries were analysed using the SPSSx statistical package 23 on the University of Newcastle network. Tests for significant associations across the clinical and demographic characteristics were completed using the chi-squared test for categorical variables. Associations significant at the 5% level and above are reported.
RESULTS
The analyses presented here are based on 669 adults for whom information about age and gender was complete. Of these, 324 were males (48%); median age of the sample was 45 years and median age of onset was 18 years. For the purposes of the analyses we defined four groups: Group 1 comprised men aged <65 and women aged <60 at the point of data collection (n = 514); Group 2 comprised men aged 65+ and women aged 60+ (n = 155). Group 2 was further subdivided into: Group 2a, which comprised men aged 65+ diagnosed before age 65 and women aged 60+ diagnosed before age 60 (n = 114); and Group 2b, which comprised men aged 65+ diagnosed at age 65+ and women aged 60+ diagnosed at 60+ (n = 32). Nine older people for whom information about age of onset was missing are excluded from the comparison between Groups 2a and 2b.
Younger adults with epilepsy (Group 1) were less likely to be widowed and more likely to be single and in employment than older adults (Group 2) (see Table 2 for marital status: χ 2 = 158.70, df. = 3, P < 0.01; for employment status χ 2 = 79.42, df. = 1, P < 0.001). A very much higher proportion of older adults lived alone (see Table 2 ). Younger adults (Group 1) more often reported generalized seizures than did older adults (Group 2) (58% compared to 34%-see Table 3 : χ 2 = 11.04, df. = 1, P < 0.001). Median. Group 1 = All men aged <65 and all women aged <60, Group 2 = All men aged 65+ and all women aged 60+, Group 2a = All men aged 65+ diagnosed before age 65 and all women aged 60+ diagnosed before age 60, Group 2b = All men aged 65+ diagnosed at 65 or over and all women aged 60+ and diagnosed at 60 or over. Group 1 = All men aged <65 and all women aged <60, Group 2 = All men aged 65+ and all women aged 60+, Group 2a = All men aged 65+ diagnosed before age 65 and all women aged 60+ diagnosed before age 60, Group 2b = All men aged 65+ diagnosed at 65 or over and all women aged 60+ and diagnosed at 60 or over.
Forty-seven percent of the respondents in Group 1 reported having been seizure-free in the last 12 months compared with 60% of Group 2 (see Fig. 1 ; χ 2 = 17.812, df. = 2, P < 0.001). Younger adults (Group 1) were more likely to report all types of seizure-related injuries (apart from other fractures) than were older adults, probably reflecting that they more often had generalized seizures and were less likely to be seizure-free (Table 4 : differences were non-significant for all types of injury except seizures while bathing/swimming (χ 2 = 5.24, df. = 1, P < 0.05)). Group 1 = All men aged <65 and all women aged <60, Group 2 = All men aged 65+ and all women aged 60+, Group 2a = All men aged 65+ diagnosed before age 65 and all women aged 60+ diagnosed before age 60, Group 2b = All men aged 65+ diagnosed at 65 or over and all women aged 60+ and diagnosed at 60 or over.
Ninety-five percent of respondents to the study reported being on antiepileptic medication, the majority receiving monotherapy (Group 1 = 66%, Group 2 = 75%, Group 2a = 66%, Group 2b = 94%). Around a fifth in each group were prescribed carbamazepine; older adults were more likely to be taking phenytoin and younger adults were more likely to be taking valproate (see Table 5 : χ 2 = 38.30, df. = 4, P < 0.001). There were marked differences in the medication regimens of older people diagnosed pre-and post-retirement (Groups 2a and 2b), the most notable being in prescribing of phenytoin. The most common complaints associated with AED treatment were CNSrelated side-effects, e.g. tiredness, sleepiness, nervousness, difficulty in concentrating and memory problems (see Table 6 ). Older people (Group 2) were more likely to report problems with unsteadiness (53% cf. 25%: χ 2 = 19.62, df. = 1, P < 0.001), upset stomach (33% cf. 26%: χ 2 = 5.60, df. = 1, P < 0.05), dizziness (42% cf. 30%: χ 2 = 3.79, df. = 1, P < 0.05) and disturbed sleep (50% cf. 37%: χ 2 = 4.11, df. = 1, P < 0.05), while younger people (Group 1) were likely to report more problems with tiredness (69% cf. 57%: χ 2 = 3.72, df. = 1, P = 0.05), feelings of aggression (35% cf. 17%: χ 2 = 8.56, df. = 1, P < 0.05) and skin problems (30% cf. 12%: χ 2 = 9.47, df. = 1, P < 0.01). A number of possible explanations for these differences present themselves, including the effects of age and different prescribing practices. There were no significant differences in reported side-effects for Groups 2a and 2b. Group 1 = All men aged <65 and all women aged <60, Group 2 = All men aged 65+ and all women aged 60+, Group 2a = All men aged 65+ diagnosed before age 65 and all women aged 60+ diagnosed before age 60, Group 2b = All men aged 65+ diagnosed at 65 or over and all women aged 60+ and diagnosed at 60 or over.
There were no obvious differences between younger and older adults for anxiety and depression. However, older adults diagnosed post-retirement age were more likely than those diagnosed pre-retirement to be both mildly anxious and mildly or moderately depressed (though the differences were not statistically significant: see Table 7 ). The majority of respondents reported no feelings of stigma. Younger adults were more likely than their older counterparts to report feeling stigmatized by their condition (see Table 7 : χ 2 = 25.50, df. = 3, P < 0.01); in particular, younger people were four times more likely to report feeling highly stigmatized. There was no difference for stigma between the two older groups (Groups 2a and 2b ).
An analysis of the responses to the impact of epilepsy scale revealed that a significant number of adults felt that their epilepsy and its treatment affected aspects of their lives (see Table 8 ). In a comparison of the responses given by younger and older adults, the differences that emerged were all in the expected direction and were statistically significant for relationship with close family members (χ 2 = 5.19, df. = 1, P < 0.05), ability to work (χ 2 = 35.24, df. = 1, P < 0.001), nature of work (χ 2 = 137.34, df. = 2, P < 0.001), overall health (χ 2 = 6.32, df. = 1, P < 0.005) and for plans and ambitions (χ 2 = 10.58, df. = 1, P < 0.01). For example, younger people were more likely to report an impact on employment and plans for the future. In the comparison between Groups 2a and 2b, none of the differences in reported impact were statistically significant. Group 1 = All men aged <65 and all women aged <60, Group 2 = All men aged 65+ and all women aged 60+, Group 2a = All men aged 65+ diagnosed before age 65 and all women aged 60+ diagnosed before age 60, Group 2b = All men aged 65+ diagnosed at 65 or over and all women aged 60+ and diagnosed at 60 or over. Group 1 = All men aged <65 and all women aged <60, Group 2 = All men aged 65+ and all women aged 60+, Group 2a = All men aged 65+ diagnosed before age 65 and all women aged 60+ diagnosed before age 60, Group 2b = All men aged 65+ diagnosed at 65 or over and all women aged 60+ and diagnosed at 60 or over. Group 1 = All men aged <65 and all women aged <60, Group 2 = All men aged 65+ and all women aged 60+, Group 2a = All men aged 65+ diagnosed before age 65 and all women aged 60+ diagnosed before age 60, Group 2b = All men aged 65+ diagnosed at 65 or over and all women aged 60+ and diagnosed at 60 or over. Group 1 = All men aged <65 and all women aged <60, Group 2 = All men aged 65+ and all women aged 60+, Group 2a = All men aged 65+ diagnosed before age 65 and all women aged 60+ diagnosed before age 60, Group 2b = All men aged 65+ diagnosed at 65 or over and all women aged 60+ and diagnosed at 60 or over.
Most of the respondents reported themselves as satisfied with their QOL (Table 9 ). However, compared with those diagnosed earlier, older people diagnosed post-retirement more often indicated that either a neutral or negative 'face' best represented their overall QOL (χ 2 = 13.05, df. = 4, P < 0.05).
DISCUSSION
To our knowledge, this study represents one of the few attempts to examine the impact of epilepsy on the physical, social and psychological well-being of older people with epilepsy, in the context of a large crosssectional study of an unselected sample of adults with this chronic condition. It also provided an opportunity to consider whether there was any significant difference in the degree of the impact of epilepsy on older people, depending on when the diagnosis was made. Some important clinical differences were noted between the younger and older adults, the former being more likely to be experiencing generalized seizures that were less well controlled. Perhaps as a result of these differences in the clinical characteristics of their condition, younger adults were more likely to report seizure-related injuries. This finding is at odds with the belief that seizure-related injuries will be more frequent in older people, as a consequence of their increasing frailty. However, it should be noted that there were relatively few old older people in this sample. Of those defined as 'older', 75% were aged under 75 and only three were aged 85 or more. Furthermore, we would urge caution in the interpretation of the findings presented in Table 4 , as the numbers of respondents in Group 2b was small. It should be noted that in an earlier analysis, we showed that another important predictor of seizure-related injury was gender 24 -in particular, women were found to be twice as likely as men to experience burns and scalds, probably as a result of their increased involvement in domestic activities.
The pattern of AED prescribing differed across the groups, older patients being more likely to be taking the older AEDs. Among older people, those diagnosed as having epilepsy post-retirement were significantly more likely than those diagnosed earlier to be prescribed phenytoin, a finding which may reflect that they were more often treated at the time of onset by non-specialist geriatricians. The incidence of perceived AED side-effects was relatively high, and the reporting of specific side-effects differed by age. Older people more often reported unsteadiness and dizziness, upset stomach, disturbed sleep and memory problems. In contrast, younger people more often reported tiredness, feelings of aggression, problems with skin, weight gain and depression. A number of possible explanations for the differential reporting of side-effects can be suggested, including that they reflect the different prescribing patterns previously highlighted. Alternatively, they may simply reflect different age-related experiences of health and well-being. There was consistent high reporting of memory problems across all the groups, which may reflect the concerns people with epilepsy have about their memory functioning-even though the evidence to date suggests that the main cause of memory problems are likely to be related to the underlying lesion and seizure activity, rather than the AEDs themselves 25 . There was no evidence that older people with epilepsy have lower levels psychological well-being than do younger people. However, older people with a later age of onset were at increased risk of anxiety and depression and more likely to assess their QOL overall either neutrally or negatively, compared to older people in whom a diagnosis had been made earlier, possibly reflect-ing that they had had less time to adjust to the onset of a chronic health problem and any associated limitations and loss of independence. In contrast, though there were no differences for stigma between the two older groups, older people as a whole were less likely to report feeling stigmatized than were younger people. This is consistent with our finding that younger people reported a greater impact of epilepsy on employment and ambitions for the future.
Our finding that rates of anxiety and depression were similar in older and younger people with epilepsy is consistent with reports from elsewhere: for example the proportions of people regarded as a case of psychiatric morbidity, as measured by the General Health Questionnaire (GHQ-30), were similar across all ages, rising only among the old older (75 plus) 26 . Though we are unable to locate parallel figures for anxiety, prevalence studies in Europe and the UK report figures of around 10-13% for moderate to severe depression in older people, and 20-22% when the less severe categories are included 27 . Thus, the rates of depression reported by our sample of older people with epilepsy do not seem significantly higher than those for ageequivalent non-epileptic populations.
There are a number of limitations to the study from which the data reported here were drawn, which have been previously addressed 11, 12 . Two important issues not considered in this analysis were the effects of losing a driving licence and the effects of losing employment as a result of a diagnosis of epilepsy and the potential impact of both these for loss of independence. The majority of older people, however, are unlikely to be in employment and consequently the impact of epilepsy in this area may be minimal. However, the loss of a driving licence has potentially much more serious consequences for independence. Older people are more likely to live alone and have limited social support, and if they are living with someone, they are more likely to be providing informal care. Our analysis has focused on QOL differences by age. However, as pointed out earlier, there were very few very old people in our sample. Further, there may also be important within-age group differences by gender which the present analysis has ignored. Future research could helpfully address these limitations in greater depth.
A further limitation of our research is our reliance on a previously specified battery of measures to assess the impact of epilepsy on QOL in older people. We would strongly recommend that any future studies should include qualitative research to ensure that the issues identified by older men and women thus affected are reflected in the measures chosen. However, just as generic QOL measures are seen as having the advantage over condition-specific ones that they allow for cross-condition comparisons, so our measure may be seen as having the advantage over an age-specific one that it has allowed comparisons to be made across different age groups of people with epilepsy.
In conclusion, it has been previously suggested that because of uncertainty about the diagnosis and unpredictability of its course, older people with epilepsy may experience a marked loss of functional independence and an accompanying decrease in aspects of their QOL 6 . Our results do not support the notion of an increased impact of epilepsy in older age per se, but that time of diagnosis is crucial. Where the diagnosis is made post-retirement, our data suggest an increased risk of perceived impact and psychological impairment. Further research is required to disentangle the various possible explanations for this difference. What is without dispute, however, is that the management of this chronic condition in older as in younger people should not only address its clinical treatment but should also aim to alleviate its psychosocial impact.
